These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10704151)

  • 1. Cell cycle regulation and RNA polymerase II.
    Bregman DB; Pestell RG; Kidd VJ
    Front Biosci; 2000 Feb; 5():D244-57. PubMed ID: 10704151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control.
    Oelgeschläger T
    J Cell Physiol; 2002 Feb; 190(2):160-9. PubMed ID: 11807820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
    Guo Z; Stiller JW
    BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFIIF-associating carboxyl-terminal domain phosphatase dephosphorylates phosphoserines 2 and 5 of RNA polymerase II.
    Lin PS; Dubois MF; Dahmus ME
    J Biol Chem; 2002 Nov; 277(48):45949-56. PubMed ID: 12351650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
    Serizawa H
    J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity.
    Edwards MC; Wong C; Elledge SJ
    Mol Cell Biol; 1998 Jul; 18(7):4291-300. PubMed ID: 9632813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity.
    Palancade B; Dubois MF; Bensaude O
    J Biol Chem; 2002 Sep; 277(39):36061-7. PubMed ID: 12138108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation independent of TFIIH kinase and the RNA polymerase II mediator in vivo.
    Lee D; Lis JT
    Nature; 1998 May; 393(6683):389-92. PubMed ID: 9620805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation state of the RNA polymerase II C-terminal domain (CTD) in heat-shocked cells. Possible involvement of the stress-activated mitogen-activated protein (MAP) kinases.
    Venetianer A; Dubois MF; Nguyen VT; Bellier S; Seo SJ; Bensaude O
    Eur J Biochem; 1995 Oct; 233(1):83-92. PubMed ID: 7588777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.
    Tamrakar S; Kapasi AJ; Spector DH
    J Virol; 2005 Dec; 79(24):15477-93. PubMed ID: 16306619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
    Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
    J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
    Rickert P; Corden JL; Lees E
    Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.
    Gold MO; Rice AP
    Nucleic Acids Res; 1998 Aug; 26(16):3784-8. PubMed ID: 9685496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1.
    Rossi DJ; Londesborough A; Korsisaari N; Pihlak A; Lehtonen E; Henkemeyer M; Mäkelä TP
    EMBO J; 2001 Jun; 20(11):2844-56. PubMed ID: 11387217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of RNA polymerase II in elongation complexes to C-terminal domain phosphatase.
    Lehman AL; Dahmus ME
    J Biol Chem; 2000 May; 275(20):14923-32. PubMed ID: 10809737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
    Devaiah BN; Singer DS
    J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.
    Gold MO; Tassan JP; Nigg EA; Rice AP; Herrmann CH
    Nucleic Acids Res; 1996 Oct; 24(19):3771-7. PubMed ID: 8871557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.